Performance Outcome Assessment Emerging Good Practices Task Force: Final Recommendations
Author(s)
Moderator: Stephen Joel Coons, PhD, Critical Path Institute, Tucson, AZ, USA
Speakers: Christopher James Edgar, MSc, PhD, Cogstate, New Haven, CT, USA; Elektra Papadopoulos, MD, MPH, AbbVie Inc., North Chicago, IL, USA; Michelle Campbell, PhD, CDER, US Food and Drug Administration, Silver Spring, MD, USA
Presentation Documents
The forum will cover the task force’s final report on emerging good measurement practice recommendations for evaluating and/or developing PerfO assessments for use in capturing clinical benefit in treatment trials. Task force members will discuss: 1. Identifying the concept of interest and determining when a PerfO assessment is the optimal approach to measuring it 2. Considerations when identifying, selecting, or modifying existing PerfO assessments or developing new ones 3. Unique challenges when evaluating content validity and other measurement properties of PerfO assessments 4. Importance of conducting a pilot evaluation of PerfO assessments in the target population Attendees will evaluate the final good practice recommendations. This feedback will form the basis of an interactive discussion with polling between the panel and the audience around the practical application of the task force’s recommendations.
Conference/Value in Health Info
Code
135